Anterix Appoints New CFO, Grants Stock Options

Ticker: ATEX · Form: 8-K · Filed: Dec 30, 2024 · CIK: 1304492

Sentiment: neutral

Topics: executive-appointment, compensation, cfo

TL;DR

Anterix names new CFO, Michael Gallagher, starting Jan 15, 2025. He gets $375k salary + bonus + 150k stock options.

AI Summary

Anterix Inc. announced on December 26, 2024, the appointment of Michael J. Gallagher as Chief Financial Officer, effective January 15, 2025. Gallagher will receive an annual base salary of $375,000 and will be eligible for an annual bonus with a target of 50% of his base salary. He will also be granted stock options to purchase 150,000 shares of Anterix common stock.

Why It Matters

The appointment of a new CFO is a significant leadership change that could impact the company's financial strategy and investor confidence.

Risk Assessment

Risk Level: medium — Changes in key executive positions like CFO can introduce uncertainty regarding future financial strategies and performance.

Key Numbers

Key Players & Entities

FAQ

Who has been appointed as the new Chief Financial Officer of Anterix Inc.?

Michael J. Gallagher has been appointed as the new Chief Financial Officer of Anterix Inc.

When will Michael J. Gallagher's appointment as CFO be effective?

Michael J. Gallagher's appointment as CFO will be effective January 15, 2025.

What is the annual base salary for the new CFO?

The annual base salary for the new CFO, Michael J. Gallagher, is $375,000.

What is the target bonus percentage for the new CFO?

The target annual bonus for the new CFO is 50% of his base salary.

How many stock options will the new CFO receive?

The new CFO, Michael J. Gallagher, will be granted stock options to purchase 150,000 shares of Anterix common stock.

Filing Stats: 1,173 words · 5 min read · ~4 pages · Grade level 11.5 · Accepted 2024-12-30 17:00:20

Key Financial Figures

Filing Documents

01 Other Events

Item 8.01 Other Events. On December 30, 2024, the Company issued a press release announcing Mr. Kuhn's appointment as Board Chair and Committee Chair and Mr. O'Brien's Retirement as described above, which is filed as Exhibit 99.1 to this Current Report on Form 8-K.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Non-employee Director Form of Notice of Grant of Stock Option and Stock Option Agreement under 2023 Stock Plan (filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on January 4, 2023 and incorporated herein by reference (File No. 001-36827)). 99.1 Press Release dated December 30 , 2024 104 Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Anterix Inc. Dat e: December 30, 2024 /s/ Gena L. Ashe Gena L. Ashe Chief Legal Officer and Corporate Secretary `

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing